{"schema_version":"secwatch.filing_event.v1","accession":"0001683168-24-000681","form_type":"8-K","ticker":"VNOV","cik":"0001699709","company_name":"VitaNova Life Sciences Corp","filed_at":"2024-02-05T23:59:59+00:00","discovered_at":"2026-05-14T18:03:25.162488+00:00","generated_at":"2026-06-06T09:12:25.647954+00:00","sec_items":["1.01","3.02","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.6,"calibrated_materiality_score":0.6,"confidence":"high","headline":"Yijia Group Corp. raises $957K via private placement of ~19.1M shares at $0.05 each","bullets":["Gross proceeds of $957,051; shares sold at $0.05 per share to 10 investors.","Two U.S. accredited investors (Reg D) and eight non-U.S. investors (Reg S) participated.","Shares are unregistered and subject to resale restrictions under the Securities Act.","Offering closed on January 30, 2024; conducted on a rolling basis with no minimum or maximum."],"urls":{"canonical":"https://secwatch.observer/filing/0001683168-24-000681","json":"https://secwatch.observer/filing/0001683168-24-000681.json","markdown":"https://secwatch.observer/filing/0001683168-24-000681.md","text":"https://secwatch.observer/filing/0001683168-24-000681.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1699709/000168316824000681/0001683168-24-000681-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1699709/000168316824000681/yijia_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-06T09:12:25.647954+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"26f207448c210c717d60c276e4239e283c8dc0fb","claim":"VitaNova Life Sciences Corp entered into Purchase Agreements with ten investors valued at aggregate gross proceeds of $957,051 (effective 2024-01-30).","evidence_excerpt":"On January 30, 2024, Yijia Group Corp. (the “Company”) entered into ten securities purchase agreements (the “Purchase Agreements”) in connection with its private offering (the “Offering”) of the Company’s unregistered shares of common stock, par value $0.001, with a total of ten (10) investors, consisting of two (2) U.S. accredited investors, as defined under Rule 501 of Regulation D, and eight (8) non-U.S. investors (individually, an “Investor” and collectively, the “Investors”), at a purchase price of $0.05 per share.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/1699709/000168316824000681/0001683168-24-000681-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"entry"},{"label":"Agreement","value":"equity purchase"},{"label":"Counterparty","value":"ten investors"},{"label":"Value","value":"aggregate gross proceeds of $957,051"},{"label":"Effective","value":"2024-01-30"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}